Drug Shortage Report for M-M-R II

Last updated on 2024-05-15 History
Report ID 221457
Drug Identification Number 00466085
Brand name M-M-R II
Common or Proper name (measles, mumps and rubella virus vaccine, live, attenuated) Lyophilized powder for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) RUBELLA VIRUS VACCINE LIVE ATTENUATED MUMPS VIRUS VACCINE LIVE ATTENUATED MEASLES VIRUS VACCINE LIVE ATTENUATED
Strength(s) 1000UNIT 5000UNIT 1000UNIT
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 10 X 1 DOSE VIAL
ATC code J07BD
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-03-08
Actual start date 2024-03-06
Estimated end date 2024-05-17
Actual end date 2024-05-14
Shortage status Resolved
Updated date 2024-05-15
Company comments Remaining doses are reserved for the public immunization program.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2024-05-15 English Compare
v12 2024-05-14 French Compare
v11 2024-05-14 English Compare
v10 2024-05-14 French Compare
v9 2024-05-14 English Compare
v8 2024-04-04 French Compare
v7 2024-04-04 English Compare
v6 2024-03-07 French Compare
v5 2024-03-07 English Compare
v4 2024-03-07 French Compare
v3 2024-03-07 English Compare
v2 2024-03-06 French Compare
v1 2024-03-06 English Compare

Showing 1 to 13 of 13